Platelet procoagulant activity induced in vivo by muromonab-CD3 infusion in uremic patients

Thrombosis Research

Volumn 104, Issue 6, 2001, Pages 405-411

  Lozano, Miguel ^a,b   Oppenheimer, Federico ^a   Cofan, Federico ^a   Rosinyol, Laura ^a   Mazzara, Roberto ^a   Escolar, Ginés ^a   Ordinas, Antonio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Flow cytometry; Muromonab CD3; Platelet activation; Platelet procoagulant activity

Indexed keywords

ANION; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5A; CD24 ANTIGEN; CD36 ANTIGEN; CD63 ANTIGEN; FIBRINOGEN RECEPTOR; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; OKT 3; PADGEM PROTEIN; PHOSPHOLIPID; PROCOAGULANT;

ADULT; ANTIBODY LABELING; ANTIGEN BINDING; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUGATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG INFUSION; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROPHYLAXIS; THROMBOCYTE; UREMIA;

ADULT; BLOOD PLATELETS; FACTOR V; FACTOR VA; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, PARENTERAL; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MUROMONAB-CD3; THROMBOPHILIA; THROMBOSIS; UREMIA;

EID: 0035894597     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00396-6     Document Type: Article

References (21)

1. A conformational epitope expressed upon association of CD-3 epsilon with either CD3-delta or CD3-gamma is the main target for recognition by anti-CD3 monoclonal antibodies
2. Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients
3. Muromonab-CD3 (drug evaluations)
4. Activation of coagulation and fibrinolysis following OKT3 administration to renal transplant recipients: Association with distinct mediators
5. Induction of thromboses within renal grafts by high-dose prophylactic OKT3
6. Monoclonal antibodies to human coagulation factor V and Va
7. Platelet concentrates prepared and stored under currently optimal conditions: Minor impact on platelet adhesive and cohesive functions after storage
8. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry
9. Activation of platelets in blood perfusing angioplasty-damaged coronary arteries - Flow cytometric detection
10. Platelet activation in mice and human Helicobacter pylori infection
11. The effects of calpeptin (a calpain-specific inhibitor) on agonist-induced microparticle formation from the platelet plasma membrane
12. Procoagulant effect of the OKT3 monoclonal antibody: Involvement of tumor necrosis factor
13. Further link between complement and blood coagulation
14. Chemotactic fragment induces leukocyte production of tissue factor activity
15. Monocyte procoagulant activity induced by in vivo administration of the OKT3 monoclonal antibody
16. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: An isolated defect in platelet procoagulant activity
17. Platelet procoagulant activity - Physiological significance and mechanisms of exposure
18. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: A flow cytometry study showing a role for free sulfhydryl groups
19. Procoagulant activity of platelet-derived microparticles formed during storage of platelet concentrates
20. Activation during preparation of therapeutic platelets affects deterioration during storage: A comparative flow cytometric study of different production methods
21. GPIIb-IIIa antagonist-induced reduction in platelet surface factor V/Va binding and phosphatidylserine expression in whole blood